Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world

Oncology experience & expertise

Oncology experience & expertise

Did you know 20% of our business is in Oncology?

We have put together a complimentary infographic displaying our experience and expertise in delivering global market research insights in Oncology, with links to a range of resources. 

read more »

  • Posted by Nicola Barclay-Prout
  • July 7, 2020
  • Blogs

Fighting talk

Fighting talk

One thing that grasps my interest is how society has adopted military style language when talking about cancer

Treatments are described as “defending” or “protecting” whilst cancer patients themselves are “fighters” who “battle” to “beat” the disease. These abstract metaphors of war are used in an attempt to articulate that cancer is a very emotional experience for all involved.
This terminology is intriguing to me, as whilst widely recognised as persuasive, it is also considered controversial.  War-like analogies suggest that there will be a “winner”, “loser”, and a “battlefield”. Sadly there are hundreds of types of cancer, and short of resection, there is no definitive cure for any of them. I have to ask myself, how do progressed metastatic patients feel anything other than failure when we talk about the disease in this way?

read more »

How 360 qualitative insights gave strategic direction into the development of an oncology biomarker

How 360 qualitative insights gave strategic direction into the development of an oncology biomarker

Our client needed to understand molecular diagnostic testing growth opportunities for a new biomarker in oncology.

We conducted 104 qualitative face-to-face and telephone interviews with a range of different stakeholders; Oncologists, Surgeons, Radiologists and Pathologists in Canada, France, Germany, Italy, Japan, Spain, UK and US. 360°feedback on the process and the involvement of individual HCP types was gleaned using a highly explorative discussion around the processes and decision points involved. From this, decision trees were developed and opportunities and threats to testing were identified.

read more »

How multi-stakeholder patient journey insights in oncology were brought to life with creative outputs and data visualisation

How multi-stakeholder patient journey insights in oncology were brought to life with creative outputs and data visualisation

Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an improved patient experience.
We carried out qualitative research with all relevant stakeholders - patients, caregivers, oncologists, haematologists and nurses in all the markets in order to get a 360 degree view of the patient journey, triangulate different viewpoints and understand where disconnects existed between stakeholders.  

read more »

Excellence in oncology

Developing an effective biomarker strategy

Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients. Payers are able to demonstrate that the treatment they are paying for will be of maximum value. Physicians feel confident that they are offering an effective drug, which is at the cutting-edge of medicine. And patients clearly benefit from a treatment programme that reduces the risk of unnecessary toxicities and offers them better outcomes.

read more »